| abstract |
The present invention provides the use of a compound of formula A in the preparation of a medicament for the treatment of glioma, in particular glioblastoma. In particular, there is provided the use of a compound of formula A in the preparation of a medicament for treating the expression of a specific fusion protein. Using the technical solutions of the present invention, glioblastoma classification can be performed, drug administration can be administered to specific patient groups, and accurate treatment can be performed. [Chemical 1] |